These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7229031)

  • 1. Reversal of hemodialysis granulocytopenia and pulmonary leukostasis: A clinical manifestation of selective down-regulation of granulocyte responses to C5adesarg.
    Skubitz KM; Craddock PR
    J Clin Invest; 1981 May; 67(5):1383-91. PubMed ID: 7229031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement, granulocytes, and shock lung.
    Craddock PR
    Am J Emerg Med; 1984 Jan; 2(1):78-81. PubMed ID: 6517988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.
    Arnaout MA; Hakim RM; Todd RF; Dana N; Colten HR
    N Engl J Med; 1985 Feb; 312(8):457-62. PubMed ID: 3881672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis.
    Stroncek DF; Keshaviah P; Craddock PR; Hammerschmidt DE
    J Lab Clin Med; 1984 Sep; 104(3):304-11. PubMed ID: 6470561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradialytic modulation of granulocyte C5a receptors.
    Himmelfarb J; Gerard NP; Hakim RM
    J Am Soc Nephrol; 1991 Oct; 2(4):920-6. PubMed ID: 1751793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The properties of human C5a anaphylatoxin. The significance of C5a formation during hemodialysis.
    Chenoweth DE
    Contrib Nephrol; 1987; 59():51-71. PubMed ID: 3327650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.
    Craddock PR; Fehr J; Dalmasso AP; Brighan KL; Jacob HS
    J Clin Invest; 1977 May; 59(5):879-88. PubMed ID: 856872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of C5a/C5a(desArg) in bovine plasma, serum and milk.
    Rainard P; Sarradin P; Paape MJ; Poutrel B
    Vet Res; 1998; 29(1):73-88. PubMed ID: 9559522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.
    Craddock PR; Hammerschmidt D; White JG; Dalmosso AP; Jacob HS
    J Clin Invest; 1977 Jul; 60(1):260-4. PubMed ID: 874088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells.
    Jalili A; Shirvaikar N; Marquez-Curtis L; Qiu Y; Korol C; Lee H; Turner AR; Ratajczak MZ; Janowska-Wieczorek A
    Exp Hematol; 2010 Apr; 38(4):321-32. PubMed ID: 20153802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aprotinin on complement and granulocyte activation during ex vivo hemodialysis.
    Himmelfarb J; Holbrook D; McMonagle E
    Am J Kidney Dis; 1994 Dec; 24(6):901-6. PubMed ID: 7527183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of density changes and chemotactic receptors of leukocytes from chronic hemodialysis and peritoneal dialysis patients.
    Lewis SL; Van Epps DE; Chenoweth DE
    Blood Purif; 1987; 5(2-3):138-54. PubMed ID: 3040039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assay.
    Reis ES; Chen H; Sfyroera G; Monk PN; Köhl J; Ricklin D; Lambris JD
    J Immunol; 2012 Nov; 189(10):4797-805. PubMed ID: 23041570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation.
    Hammerschmidt DE; Bowers TK; Lammi-Keefe CJ; Jacob HS; Craddock PR
    Blood; 1980 Jun; 55(6):898-902. PubMed ID: 6991024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis.
    Himmelfarb J; McMonagle E; Holbrook D; Toth C
    J Lab Clin Med; 1995 Oct; 126(4):392-400. PubMed ID: 7561449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylatoxin formation in extracorporeal circuits.
    Chenoweth DE
    Complement; 1986; 3(3):152-65. PubMed ID: 3492330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin-induced shock in the rat. A role for C5a.
    Smedegård G; Cui LX; Hugli TE
    Am J Pathol; 1989 Sep; 135(3):489-97. PubMed ID: 2789475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of leukocyte regulation by complement-derived factors.
    Hugli TE; Morgan EL
    Contemp Top Immunobiol; 1984; 14():109-53. PubMed ID: 6331985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional characterization of human and murine C5a anaphylatoxins.
    Schatz-Jakobsen JA; Yatime L; Larsen C; Petersen SV; Klos A; Andersen GR
    Acta Crystallogr D Biol Crystallogr; 2014 Jun; 70(Pt 6):1704-17. PubMed ID: 24914981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.